Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Janssen Pharmaceuticals; Bayer AG; Merck/Schering Plough